Multiple Sclerosis: Subtypes, Symptoms, and Treatment: Publications and Documents
Summary
The Disabled World list of publications on Multiple Sclerosis offers a comprehensive collection of articles and papers covering various aspects of the disease. These resources explore MS subtypes, such as relapsing-remitting and primary progressive, as well as common symptoms like fatigue, vision problems, and mobility issues. The list includes peer-reviewed research on diagnostic techniques, including MRI scans and spinal fluid analysis, along with detailed information on treatment options ranging from disease-modifying therapies to symptom management strategies. Many articles provide practical advice for daily living with MS, discussing topics like exercise, nutrition, and cognitive rehabilitation. This diverse array of publications serves as a valuable resource for individuals with MS, their caregivers, healthcare professionals, and researchers, offering insights into the latest developments in MS care and support.Searching the Database
The data table below lists items that may have been updated or revised, but the table defaults to sorting by descending publication date; you can search and sort by clicking column headers (JavaScript required). Items in this category are also distributed via our Multiple Sclerosis: Subtypes, Symptoms, and Treatment RSS feed.
| Title and Description | Ed | Publish Revised |
|---|---|---|
| New Multiple Sclerosis Treatment Clinical Trial Begins Enrollment Clinical trial of Autologous Hematopoietic Stem Cell Transplantation versus Best Available Therapy for Multiple Sclerosis (BEAT-MS) begins enrollment. | ||
| Stigma Increases Risk of Depression for People with Multiple Sclerosis Those with MS who feel stigmatized are more likely to have depression, having a support system of friends and family and a sense of autonomy may help reduce the harmful effects of stigma.. | ||
| $7M MS Progression Cohort to Research Multiple Sclerosis in Canada Research proposals will invite researchers to establish a Canadian cohort of people living with MS to study progression in the disease. | ||
| How Can We Predict Whose Multiple Sclerosis Will Worsen? Multiple Sclerosis study brings us closer to understanding which older adults with MS may be at higher risk of getting worse. | ||
| Cladribine Significantly Reduces Brain Atrophy in Patients with Multiple Sclerosis Phase III CLARITY study data revealed significant reduction in brain atrophy in patients on short course of investigational Cladribine Tablets over two years. | ||
| Multiple Sclerosis Onset Age Linked to Geographic Latitude Study finds the age at which symptoms of multiple sclerosis (MS) first start is strongly linked to latitude. | ||
| Stem Cells Show Reversal of Disability in Multiple Sclerosis Stem cell treatment improves established disability in patients with progressive MS and shows there is hope future treatment is possible. | ||
| Multiple Sclerosis Research Progress and Initiatives Summary of significant 2015 multiple sclerosis research progress and initiatives from The National Multiple Sclerosis Society. | ||
| New Multiple Sclerosis (MS) Drug Target Discovered New research could lead to the development of new types of drugs to treat Multiple Sclerosis (MS). | ||
| Multiple Sclerosis - HPV Vaccination No Increased Risk Follow-up of girls and women who received human papillomavirus (HPV) vaccination found no increased risk for these disorders. | ||
| A Step Closer to Cell Therapy for MS Patients Research scientists are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patients own cells. | ||
| Link Between Dental Mercury Fillings and MS Examined Case discovered that her inability to walk and other MS symptoms were triggered by her dental mercury fillings. | ||
| FAMPYR Now Available in Canada for Improvement of Walking in MS Health Canada approved FAMPYRA on February 10, 2012 for the symptomatic improvement of walking in adult MS patients with walking disability. | ||
| Symptom Relief in MS Patients Seen by Interventional Radiologists Minimally invasive endovascular treatment for CCSVI may produce significant improvement in physical and mental quality of life in individuals with MS. | ||
| Major Breakthrough in Multiple Sclerosis Found Using Upright MRI Diagnostic breakthrough in multiple sclerosis reveals cause may be bio-mechanical related to earlier trauma to the neck resulting in obstruction of cerebrospinal fluid flow. | ||
| Breakthrough in Search for Multiple Sclerosis Treatment Molecular mechanism could bring about the development of new treatments for Multiple Sclerosis (MS). | ||
| Minimally Invasive Treatment for MS Patients Endovascular therapy or angioplasty is the nonsurgical procedure of threading a thin tube into a vein or artery to open blocked or narrowed blood vessels. | ||
| Shingles May Be Related to Elevated Risk of Multiple Sclerosis There is epidemiological evidence that some herpes viruses may contribute to multiple sclerosis (MS) occurrence. | ||
| Viagra May Reduce MS Symptoms Viagra drastically reduces multiple sclerosis symptoms in animal models with the disease. | ||
| SR1001 Compound Halts Progression of Multiple Sclerosis (MS) Scientists develop compound that effectively halts progression of multiple sclerosis (MS), the discovery also holds promise for other autoimmune disorders. | ||
| Disability Timeline for Progressive Multiple Sclerosis (MS) By noting the presence of markers in a diagnostic test, researchers predict whether patients will suffer faster onset of disability and counsel them to help ease anxiety. | ||
| Novartis Therapy Gilenya Reduced Risk of MS Disability Progression Gilenya delayed progression of disability both for patients who were previously treated for their MS and for patients who had not received prior treatment. | ||
| Treating Multiple Sclerosis Damage to Nerve Cells Multiple sclerosis is a seriously disabling autoimmune disease that can lead to disturbance or loss of sensory function voluntary movement vision and bladder control. | ||
| Monitoring System for Multiple Sclerosis - Canada People living with MS need more information to make the best choices for the benefit of their health. | ||
| MS - How Do You Put a Face on a Disease that Affects Each Person Differently Multiple sclerosis is a life altering disease that affects each person in a unique and different way. | ||
| Multiple Sclerosis Oral Treatment Approved in Canada Gilenya (fingolimod) is the first disease modifying oral therapy developed for the relapsing-remitting form of multiple sclerosis (MS). | ||
| Fumaric Acid Salts for Psoriasis May Help Multiple Sclerosis Fumaric acid salts used against severe psoriasis may also have a favorable effect on Multiple Sclerosis as a result of their TH2 polarizing mechanisms. | ||
| Reduced Levels of Neurotransmitter in MS Damage to a particular area of the brain and a consequent reduction in noradrenaline are associated with multiple sclerosis. | ||
| Histamine as Multiple Sclerosis Treatment Target Peer-reviewed research reveals histamine's role in modulating immune response and reducing MS symptoms, pointing to new autoimmune disease therapies. | ✓ ✓ | |
| Progress in Multiple Sclerosis Research Multiple Sclerosis (MS) Progress was made toward finding ways to restore function and improving quality of life through exercise meditation rehabilitation and medications. | ||
| New Possibility of Reversing Damage Caused by MS Damage caused by multiple sclerosis could be reversed by activating stem cells that can repair injury in the central nervous system. | ||
| Multiple Sclerosis Will Become a Controlled Disease The complexity of the immune system and nervous system turn Neuroimmunology into one of the most exciting fields of modern biomedicine. | ||
| Ocrelizumab Shows Significant Reduction in Multiple Sclerosis Disease Activity Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients. | ||
| Asthma Medication May Benefit Patients with Multiple Sclerosis Albuterol sulfate used to treat bronchospasm in asthma may decrease interleukin-12 levels. | ||
| CIHR Makes Recommendations on Canadian MS Research Priorities Meeting of leading North American experts in multiple sclerosis (MS) to identify research priorities for Canada. | ||
| Bone Marrow Stem Cells in MS Show Promise Trial to test bone marrow stem cell therapy with patients with multiple sclerosis shown to have possible benefits for treatment of the disease. | ||
| SIR Position on Interventional MS Treatment Research Society of Interventional Radiology position statement supporting clinical research into CCSVI and endovascular treatments for multiple sclerosis patients. | ✓ ✓ | |
| Encouraging Results for Multiple Sclerosis Treatment Hard To Treat Diseases - Scientists report results that are encouraging for the future of Multiple Sclerosis Treatment. | ||
| Ampyra for Adults with Multiple Sclerosis FDA approves Ampyra (dalfampridine) drug to improve walking in patients with multiple sclerosis (MS). | ||
| New Drug Cladribine for Multiple Sclerosis Shows Promise Major trial of oral drug Cladribine has shown it significantly reduces relapse and deterioration of multiple sclerosis (MS). | ||
| National MS Society Continues to Propel Research Forward to End MS Several papers published this year provided more evidence that starting on MS therapies early after disease onset, or even before a definite diagnosis, can pay off later by delaying disease progression. | ||
| Multiple Sclerosis Relapses and Severe Disability People with multiple sclerosis who have relapses within five years of onset have more severe disability in the short term. | ||
| Possible New Underlying Cause of Multiple Sclerosis Research study could overturn the prevailing wisdom on the cause of multiple sclerosis (MS). | ||
| Genes Identified as Potential Therapeutic Targets for Multiple Sclerosis Study finds two genes associated with good central nervous system repair in multiple sclerosis. | ||
| Brain Disease Virus Found in Natalizumab Treated MS Patients Virus responsible for rare brain disease found to be reactivated in multiple-sclerosis patients being treated with natalizumab. | ||
| Researchers Successfully Reverse Multiple Sclerosis A new experimental treatment for multiple sclerosis (MS) completely reverses the devastating autoimmune disorder. | ||
| Antegren Drug for Relapsing MS Antegren for multiple sclerosis is a monoclonal antibody that is given by monthly infusion into a vein. | ||
| Naltrexone Offers Promise for MS but Lacks Access Low-dose naltrexone shows promise in halting MS progression and improving quality of life, but patients struggle to access the treatment due to lack of clinical trials. | ✓ ✓ | |
| Drug Improves Mobility For Some Multiple Sclerosis Patients Experimental drug fampridine 4-aminopyridine improves walking ability in some individuals with multiple sclerosis MS. |
Key: the first check mark indicates the publication carries an editor's note; the second indicates a footnote.
Note: Disabled World compiles disability-related publications as a resource. Inclusion does not imply endorsement by Disabled-World.com. To submit disability-related articles and peer-reviewed manuscripts and papers, ensure submissions comply with our guidelines. For questions, please contact us.
Back to Multiple Sclerosis: Subtypes, Symptoms, and Treatment Index.